Back to Browse Journals » International Journal of High Throughput Screening » Volume 2

Drug discovery in Parkinson's disease: update and developments in the use of cellular models

Authors Skibinski G, Finkbeiner S

Published 30 June 2011 Volume 2011:2 Pages 15—25


Review by Single-blind

Peer reviewer comments 3

Gaia Skibinski, Steven Finkbeiner
Gladstone Institute of Neurological Disease, San Francisco, CA, USA

Abstract: Parkinson's disease is the second most common neurodegenerative disorder and is characterized by the degeneration of dopaminergic neurons within the substantia nigra. Dopamine replacement drugs remain the most effective treatment for Parkinson's disease but only provide temporary symptomatic relief. New therapies are urgently needed, but the search for a disease-modifying treatment and a definitive understanding of the underlying mechanisms of Parkinson's disease has been limited by the lack of physiologically relevant models that recapitulate the disease phenotype. The use of immortalized cell lines as in vitro model systems for drug discovery has met with limited success, because efficacy and safety too often fail to translate successfully in human clinical trials. Drug discoverers are shifting their focus to more physiologically relevant cellular models, including primary neurons and stem cells. The recent discovery of induced pluripotent stem cell technology presents an exciting opportunity to derive human dopaminergic neurons from patients with sporadic and familial forms of Parkinson's disease. We anticipate that these human dopaminergic models will recapitulate key features of the Parkinson's disease phenotype. In parallel, high-content screening platforms, which extract information on multiple cellular features within individual neurons, provide a network-based approach that can resolve temporal and spatial relationships underlying mechanisms of neurodegeneration and drug perturbations. These emerging technologies have the potential to establish highly predictive cellular models that could bring about a desperately needed revolution in Parkinson's disease drug discovery.

Keywords: Parkinson's disease, cellular models, drug delivery

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:


Skibinski G, Finkbeiner S

International Journal of High Throughput Screening 2011, 2:27-28

Published Date: 22 September 2011

Readers of this article also read:

Evaluation of calcified carotid atheroma on panoramic radiographs and Doppler ultrasonography in an older population

Atalay Y, Asutay F, Agacayak KS, Koparal M, Adali F, Gulsun B

Clinical Interventions in Aging 2015, 10:1121-1129

Published Date: 8 July 2015

Bridging the digital divide in older adults: a study from an initiative to inform older adults about new technologies

Wu YH, Damnée S, Kerhervé H, Ware C, Rigaud AS

Clinical Interventions in Aging 2015, 10:193-201

Published Date: 9 January 2015

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making

Nnabugwu II, Ugwumba FO, Enivwenae OA, Udeh EI, Otene CO, Nnabugwu CA

Clinical Interventions in Aging 2015, 10:89-93

Published Date: 30 December 2014

A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis

Wang R, Zhang D, Zhao JZ, Wang S, Zhao YL, Niu HC

Neuropsychiatric Disease and Treatment 2014, 10:2231-2237

Published Date: 19 November 2014

Proposed criteria for schizophrenia remission

AlAqeel B

Neuropsychiatric Disease and Treatment 2014, 10:619-623

Published Date: 16 April 2014

Sertraline-induced pseudocholinesterase enzyme deficiency

Beyazit Zencirci

International Journal of General Medicine 2010, 3:375-378

Published Date: 16 November 2010

Obesity and respiratory diseases

Christopher Zammit, Helen Liddicoat, Ian Moonsie, et al

International Journal of General Medicine 2010, 3:335-343

Published Date: 20 October 2010